Daewon Pharmaceutical Co., Ltd. (003220.KS) KSC

11,470.00

-30(-0.26%)

Updated at January 14 03:30PM

Currency In KRW

Valuation

Market Cap303.38B
Enterprise Value473.57B
P/E Ratio-15.34
PEG Ratio0.05
Price/Sales Ratio0.42
Price/Book Ratio0.96
Enterprise/Revenue0.74
Enterprise/EBITDA5.14

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-0.03
Operating Margin0

Management Effectiveness

Return On Assets-0.03
Return On Equity-0.06

Income Statement

Revenue598.16B
Revenue/Share27,542.23
Gross Profit287.33B
EBITDA45.56B
Net Income14.21B
Diluted EPS655.37

Balance Sheet

Total Cash68.22B
Total Cash/Share3,180.72
Total Debt213.42B
Total Debt/Equity0.83
Current Ratio1.2
Book Value Per Share12,303.38

Price History

52-Week Change-22.03
52-Week High15,350
52-Week Low11,240
Moving Average 50 Days12,451.4
Moving Average 200 Days13,103.2

Statistics

Average Volume37,381
Shares Outstanding21.43M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.4
Last Split Factor103:100
Last Split DateMarch 07, 2022